Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Reddy, Sujana, Fayyad, Rana, Edgar, Chris J, Guico-Pabia, Christine J, Wesnes, Keith · 2016 · Journal of Psychopharmacology

Abstract

The objective of this substudy was to examine the effect of desvenlafaxine 50 mg/day compared with placebo on cognitive function in employed outpatients with major depressive disorder. A total of 11/55 (20%) study sites in a 12-week, randomized, double-blind, placebo-controlled trial administered cognitive assessments in memory, attention, and executive functioning domains using the cognitive drug research system. Changes from baseline were subjected to analysis of covariance with baseline levels as covariates, using last observation carried forward data. A significant improvement with desvenlafaxine 50 mg/day ( n=52) compared with placebo ( n=29) was observed on the quality of working memory composite measure (0.081 units (0.005, 0.156); P=0.0365) at last observation carried forward. Improvement from baseline on the speed of working memory composite was significant for desvenlafaxine (−226.6 msec (−316.7, −136.4); P<0.0001) and for placebo (−133.3 msec (−257.2, −9.4); P=0.0354); however, the treatment effect was not significant. No significant differences between groups were observed on composite measures for attention. Treatment of depression with desvenlafaxine 50 mg/day may improve aspects of cognitive functioning, including working memory. Clinical Trial Registry No.: Clinicaltrials.gov identifier: NCT00824291

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881116631649

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 4

  1. Clayton A, 2014, J Clin Psychiatry
  2. Frodl T, 2006, J Psychiatry Neurosci, 31, 316
  3. Greer TL, 2014, Depress Res Treat, 2014, 627863
  4. Wagner G, 2008, J Psychiatry Neurosci, 33, 199

Cited by

See all 17

Metadata

Authors
Reddy, S., Fayyad, R., Edgar, C. J., Guico-Pabia, C. J., & Wesnes, K.
Affiliations
  • Wyeth (US)
  • Pfizer (United States) (US)
  • Formerly of Bracket Global, Goring-on-Thames, UK
  • Formerly of Pfizer Inc., formerly Wyeth Research, Collegeville, PA, USA
  • Northumbria University (GB)
Corresponding author
Reddy, Sujana
Venue
Journal of Psychopharmacology
Published
2016-03-23
Volume
30
Issue
6
Pages
559-567
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2334214451
Cited by
17
References
56
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 1
FWCI
1.89
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Northumbria Research Link (Northumbria University) (submittedVersion)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
desvenlafaxine, major depressive disorder, cognitive function, working memory, attention, executive function, norepinephrine reuptake inhibitors
MeSH terms
Desvenlafaxine Succinate, Adult, Antidepressive Agents, Cognition, Major Depressive Disorder, Double-Blind Method, Female, Humans, Male, Middle Aged, Outpatients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1177/0269881116631649
The paper
Reddy, S., Fayyad, R., Edgar, C. J., Guico-Pabia, C. J., & Wesnes, K. (2016). The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology. https://doi.org/10.1177/0269881116631649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.